Back to Hematology
Hematologyv2017 GibsonEvidence-Based

IMPROVEDD Risk Score for Venous Thromboembolism (VTE)

Predicts 77-day risk of acute venous thromboembolism (VTE) in hospitalized medical patients by incorporating D-dimer levels into the IMPROVE Risk Score. The IMPROVEDD (IMPROVE + D-dimer) score enhances the original IMPROVE VTE risk assessment by adding D-dimer ≥2× upper limit of normal as an additional risk factor worth 2 points. This validated clinical prediction tool was developed from the APEX trial involving 7,441 hospitalized medically ill patients. The addition of D-dimer significantly improves VTE risk discrimination and reclassification compared to the original IMPROVE score. An IMPROVEDD score ≥2 identifies patients with heightened VTE risk through 77 days, helping clinicians make more informed decisions about extended thromboprophylaxis duration in acutely ill medical patients.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The IMPROVEDD Risk Score for Venous Thromboembolism (VTE) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within hematology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = Previous VTE (3) + Known thrombophilia (2) + Current lower-limb paralysis (2) + Current cancer (2) + Immobilized ≥7 days (1) + ICU/CCU stay (1) + Age >60 years (1) + D-dimer ≥2×ULN (2)

Clinical Pearls & Practice Notes

  • Enhanced version of IMPROVE VTE score by adding D-dimer measurement
  • Developed from APEX trial with 7,441 hospitalized medically ill patients
  • Score <2 indicates low VTE risk, pharmacologic thromboprophylaxis not warranted
  • Score ≥2 indicates increased VTE risk, start pharmacologic or mechanical prophylaxis
  • D-dimer ≥2× ULN adds 2 points and significantly improves risk discrimination
  • Predicts 77-day VTE risk (extended period compared to original IMPROVE 3-month risk)
  • Addition of D-dimer improves AUC discrimination by 0.06 (p=0.0006)
  • Continuous net reclassification improvement: 0.34 (95% CI: 0.17-0.51)
  • Patients with IMPROVEDD ≥2 have 2.73× higher VTE risk (HR: 2.73, 95% CI: 1.52-4.90)
  • D-dimer independently associated with symptomatic VTE (adjusted HR: 2.22)
  • Used in MARINER trial for extended thromboprophylaxis patient selection
  • Consider bleeding risk assessment (e.g., IMPROVE Bleeding Risk Score) before anticoagulation
  • May be particularly useful for identifying patients who benefit from extended prophylaxis
  • D-dimer measurement should be obtained at hospital admission for optimal assessment
  • Score should be reassessed if clinical status or D-dimer levels change significantly

Evidence & Literature Citations

  1. Gibson CM, Spyropoulos AC, Cohen AT, et al. The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification. TH Open. 2017 Oct 9;1(1):e56-e65. doi: 10.1055/s-0037-1603929.
  2. Spyropoulos AC, Lipardi C, Xu J, et al. Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis. TH Open. 2020 Mar 6;4(1):e59-e65. doi: 10.1055/s-0040-1705137.
  3. Spyropoulos AC, Anderson FA Jr, FitzGerald G, et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011 Sep;140(3):706-714. doi: 10.1378/chest.10-1944.

Score Interpretation Ranges

Very Low Risk0 – 0 pts

Score 0 points

Low Risk1 – 1 pts

Score 1 point

Moderate Risk2 – 2 pts

Score 2 points

Moderate-High Risk3 – 3 pts

Score 3 points

High Risk4 – 4 pts

Score 4 points

Very High Risk5 – 14 pts

Score 5-14 points

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.